• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视力受损作为帕金森病视幻觉的一个危险因素。

Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.

作者信息

Matsui Hideaki, Udaka Fukashi, Tamura Akiko, Oda Masaya, Kubori Tamotsu, Nishinaka Kazuto, Kameyama Masakuni

机构信息

Department of Neurology, Sumitomo Hospital, Osaka, Japan.

出版信息

J Geriatr Psychiatry Neurol. 2006 Mar;19(1):36-40. doi: 10.1177/0891988705284739.

DOI:10.1177/0891988705284739
PMID:16449759
Abstract

Pathophysiology of hallucinations in Parkinson's disease is poorly understood. This study investigated relationships between visual hallucinations and visual acuity. Twenty-six consecutive patients with Parkinson's disease participated in this study. Patients were divided into two groups: patients with visual hallucinations (VH group) and those without visual hallucinations (no-VH group). Unaided and corrected eyesight was evaluated in all patients, and if frequent use of prescription glasses or contact lenses was involved, eyesight using these lenses was also measured as the patient's own best eyesight. If a patient did not use prescription glasses or contact lenses, the patient's own best eyesight was defined as the unaided eyesight. Multivariate regression analysis demonstrated that agonist use and best eyesight were different after the backward elimination method. Visual hallucinations were closely related not to uncorrected eyesight or unaided eyesight but to the patient's best eyesight. It is suggested that impaired visual acuity is a risk factor for visual hallucinations.

摘要

帕金森病幻觉的病理生理学机制目前尚不清楚。本研究调查了视幻觉与视力之间的关系。26例连续的帕金森病患者参与了本研究。患者被分为两组:有视幻觉的患者(VH组)和无视幻觉的患者(无VH组)。对所有患者评估了裸眼视力和矫正视力,如果患者经常使用处方眼镜或隐形眼镜,则使用这些镜片时的视力也作为患者的最佳视力进行测量。如果患者不使用处方眼镜或隐形眼镜,则将患者的最佳视力定义为裸眼视力。多因素回归分析表明,采用向后剔除法后,激动剂的使用情况和最佳视力存在差异。视幻觉与未矫正视力或裸眼视力并无密切关系,而是与患者的最佳视力密切相关。提示视力受损是视幻觉的一个危险因素。

相似文献

1
Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.视力受损作为帕金森病视幻觉的一个危险因素。
J Geriatr Psychiatry Neurol. 2006 Mar;19(1):36-40. doi: 10.1177/0891988705284739.
2
Poor visual discrimination and visual hallucinations in Parkinson's disease.帕金森病中的视觉辨别力差和视幻觉
Clin Neuropharmacol. 1998 Sep-Oct;21(5):289-95.
3
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.年龄对帕金森病患者新发幻觉临床特征的影响。
Mov Disord. 2006 Feb;21(2):267-70. doi: 10.1002/mds.20701.
4
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].[两例帕金森病患者白内障手术后视幻觉消失]
No To Shinkei. 2004 Apr;56(4):351-4.
5
Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.帕金森病患者视幻觉与快速眼动睡眠行为障碍之间的关系。
Clin Neurol Neurosurg. 2007 Dec;109(10):862-7. doi: 10.1016/j.clineuro.2007.08.010.
6
Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.昂丹司琼,一种5-羟色胺3拮抗剂,用于治疗晚期帕金森病中与慢性左旋多巴治疗相关的视幻觉和偏执妄想障碍。
Adv Neurol. 1996;69:541-4.
7
[Hallucinations in Parkinson's disease].[帕金森病中的幻觉]
Nervenarzt. 2003 Apr;74(4):376-85, quiz 385-6. doi: 10.1007/s00115-003-1511-8.
8
Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.对于患有帕金森病且已有视幻觉的患者,皮下持续输注阿扑吗啡可安全使用。
Parkinsonism Relat Disord. 2010 Jan;16(1):71-2. doi: 10.1016/j.parkreldis.2009.05.006. Epub 2009 Jun 12.
9
[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].[152例帕金森病患者的幻觉、妄想及夜间事件:一项区域调查]
Rev Neurol (Paris). 2002 Feb;158(2):203-10.
10
Hallucinations in Parkinson's disease: a follow-up study.帕金森病中的幻觉:一项随访研究。
Mov Disord. 2005 Feb;20(2):212-7. doi: 10.1002/mds.20263.

引用本文的文献

1
Global research trends and hotspots in Parkinson's disease psychosis: a 25-year bibliometric and visual analysis.帕金森病精神病的全球研究趋势与热点:一项25年的文献计量学与可视化分析
Front Aging Neurosci. 2024 Nov 22;16:1480234. doi: 10.3389/fnagi.2024.1480234. eCollection 2024.
2
Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.神经影像学和液体生物标志物在靶向干预时代的帕金森病。
Nat Commun. 2024 Jul 5;15(1):5661. doi: 10.1038/s41467-024-49949-9.
3
Retinal alpha-synuclein accumulation correlates with retinal dysfunction and structural thinning in the A53T mouse model of Parkinson's disease.
在帕金森病的A53T小鼠模型中,视网膜α-突触核蛋白的积累与视网膜功能障碍和结构变薄相关。
Front Neurosci. 2023 May 5;17:1146979. doi: 10.3389/fnins.2023.1146979. eCollection 2023.
4
Modulation of cortical resting state functional connectivity during a visuospatial attention task in Parkinson's disease.帕金森病患者在视觉空间注意力任务期间皮质静息态功能连接的调制
Front Neurol. 2022 Aug 9;13:927481. doi: 10.3389/fneur.2022.927481. eCollection 2022.
5
Two-year longitudinal follow-up of visual illusions and hallucinations in Parkinson's disease.帕金森病中视错觉和幻觉的两年纵向随访。
J Neurol. 2022 Aug;269(8):4546-4554. doi: 10.1007/s00415-022-11074-2. Epub 2022 Mar 16.
6
An Eye on Movement Disorders.关注运动障碍
Mov Disord Clin Pract. 2021 Aug 10;8(8):1168-1180. doi: 10.1002/mdc3.13317. eCollection 2021 Nov.
7
Face pareidolia is associated with right striatal dysfunction in drug-naïve patients with Parkinson's disease.面幻视与未经药物治疗的帕金森病患者纹状体功能障碍有关。
Neurol Sci. 2021 Dec;42(12):5327-5334. doi: 10.1007/s10072-021-05238-7. Epub 2021 Apr 22.
8
Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.视网膜作为研究帕金森病 A53T 小鼠模型中 α-突触核蛋白体内传播的模型。
Methods Mol Biol. 2021;2224:75-85. doi: 10.1007/978-1-0716-1008-4_5.
9
Motor Asymmetry and Interocular Retinal Thickness in Parkinson's Disease.帕金森病中的运动不对称和双眼视网膜厚度。
J Korean Med Sci. 2021 Feb 8;36(6):e50. doi: 10.3346/jkms.2021.36.e50.
10
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.帕金森病眼部的多巴胺、α-突触核蛋白与线粒体功能障碍
Front Neurosci. 2020 Oct 19;14:567129. doi: 10.3389/fnins.2020.567129. eCollection 2020.